Scientists led by Morgridge Institute for Research investigator Phillip Newmark have isolated a potent kryptonite against the parasitic worms, which cause devastating health problems.
Researchers at the University of Wisconsin–Madison have packed a gene-editing payload into a customizable, synthetic nanocapsule.
As outbreaks on Pacific islands and in the Americas in recent years made Zika virus a pressing public health concern, the Zika virus’s close similarity to dengue presented the possibility that one infection may exacerbate the other.
A team of biomedical engineers and clinician-scientists borrowed molecules from the immune system of the parasitic sea lamprey to deliver anti-cancer drugs directly to brain tumors.
A new study lends support to the idea that inflammation may play a key role in the development of the degenerative neurological disorder.
Dogs started receiving a vaccine against cancer this week in a clinical trial at UW-Madison. If the vaccine works in dogs, it may not only provide a new strategy for addressing a critical canine health concern, it might also work in people.
The research team is now working to obtain FDA approval for a first human clinical trial to treat devastating injuries in musculoskeletal tissues.
New battery-free, easily implantable weight-loss devices developed by engineers at the University of Wisconsin–Madison could offer a promising new weapon for battling the bulge.
New research is a first step toward understanding the way Ritalin affects the organization of the pathways that build brain networks used in attention and learning.
The bandage developed by UW-Madison engineers leverages energy generated from a patient’s own body motions to apply gentle electrical pulses at the site of an injury.